Bumrungrad Hospital (BH) Q1 2026 earnings summary

Executive summary

• Revenue for Q1 2026 reached THB 6,254 million, up slightly from THB 6,208 million year-over-year.

• Net profit attributable to equity holders was THB 1,790 million, an increase from THB 1,734 million in Q1 2025.

• Total assets grew to THB 38,710 million as of 31 March 2026, compared to THB 36,459 million at year-end 2025.

• The auditor issued an unqualified review conclusion on the interim financial statements.

Financial highlights

• Operating profit for Q1 2026 was THB 2,173 million, up from THB 2,083 million year-over-year.

• Basic EPS was THB 2.25, up from THB 2.18 in Q1 2025; diluted EPS was THB 2.06, up from THB 2.00.

• Cash and cash equivalents decreased to THB 3,922 million from THB 7,595 million at year-end 2025.

• Total shareholders’ equity increased to THB 32,974 million from THB 31,171 million at year-end 2025.

Outlook and guidance

• No changes in segment organization or reporting structure for 2026.

• New and revised accounting standards effective from 2026 had no significant impact.